Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adrenomedullin and inflammatory responses to one-lung ventilation in lobectomy
ChiCTR-IPR-16007847Phase 4Not yet recruiting
- Sponsor
- The 2nd Affiliated Hospital of Harbin Medical University
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of fispemifene in not applicable; "lung injury" is not a specific disease and inflammation (2 arms), sponsored by The 2nd Affiliated Hospital of Harbin Medical University. Primary endpoints: oxygen index, tumor necrosis factor and 3 more. Planned start Mar 2016; status: not yet recruiting.
02
Drugs
fispemifene
03
Conditions
not applicable; "lung injury" is not a specific diseaseinflammation
Beyond the preview
Go deeper on ChiCTR-IPR-16007847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16007847.